eCOA software for better clinical trials
eCOAs (electronic Clinical Outcome Assessments) and digital outcome measures delivered at industry-leading speed and quality to enhance your trial findings and fuel medical breakthroughs.
eCOA+ is part of Medable's unified data collection platform, which includes eConsent, telehealth, and sensors, with standardized integrations into your existing clinical ecosystem.
Medable eCOA+
Faster study build time
Pre-built and validated instruments
Available languages
Take eCOA off the critical path
Rapidly deploy quality studies and take eCOA off the critical path of study start-up with a reusable instrument library of 400+ standardized workflows and AI-enabled, purpose-built technology so you can work on what matters most, advancing patient care.
Unlock insights with real-time data capture
Capture objective and subjective participant data in a standardized and compliant manner. Medable’s eCOA+ combines eClinROs, ePROs, ePerfOs, eObsROs, and digital measures, so you can uncover clinically meaningful insights in real-time.
Engage patients with a better experience
Medable’s eCOA clinical trial solution improves inclusivity and accessibility, meeting the needs of patients in any geographic location and across diverse therapeutic areas, reducing burden and increasing retention.
The Medable difference
Reusable eCOA Library
Our library of 400+ reusable, pre-validated instruments, assessments and diaries ensure a standardized, consistent method of data collection that drives real-time decision making.
BYOD and provisioned devices
Accessible across web and/or mobile, provisioned devices or BYOD, unlocking patient populations that were previously out of reach while increasing patients' optionality.
Cross-platform TeleVisit
One seamless platform experience allows site and patient users to better engage and participate in a comfortable environment, reducing burden and increasing compliance.
Digital measures
Standardized integrations for sensors capturing digital physiological measures provide value across a variety of therapeutic areas including Oncology, Immunology, Cardiovascular, and more.
User friendy Platform
Consumer-grade UX, complete with notifications, reports, and submission-ready data, is vetted by our Patient Caregiver Network (PCN) and clinicians, ensuring accessibility.
24/7 Customer Support
Global customer care support throughout your trial for sites, patients and study teams. Our team ensure the best user experience to enable seamless technology adoption, protocol compliance, and overall user satisfaction.
Globally Compliant
Available in 70+ countries and 120+ locales, Medable’s platform adheres to standards set by the FDA, CFR21 Part 11, HIPAA, and GDPR.
Powered by AI
By harnessing intelligent automation, we can reduce delivery timelines by up to 50%, enabling an accelerated study start up to quickly capture novel endpoints.
Case study: Scaling global vaccine mega-trials for a top-5 pharma
Learn how Medable enabled a top-5 pharma to scale vaccine mega-trials with near-100% enrollment, real-time safety data, and >90% diary compliance.
eCOA+ Streamlined Evidence Generation
Frequently asked questions
eCOA stands for electronic clinical outcome assessment and uses electronic devices like tablets, desktop computers, and phones to collect data from trial participants. Participants complete diaries, questionnaires, or other prompts to communicate how they are feeling or functioning during the course of a clinical trial. eCOAs are part of the decentralized clinical trial (DCT) methodology and are essential to understanding whether a drug is reducing symptoms and improving patients’ quality of life.
Medable’s eCOA offering is part of our broader evidence generation offering: Patient-First Data Collection. Medable’s tools allow teams to build eCOA instruments (both validated instruments and eDiaries) that meet industry standards. Data collected from this system can be used for primary endpoints in pivotal studies. Study teams can store instruments, including translations, in a library for rapid deployment in future studies. Dashboards keep teams informed of all startup activities along the way. Teams may also access their library of prebuilt, validated instruments to improve study startup.
Yes. Medable's platform is multimodal, meaning patients can access our interface through the Patient app or a web browser. A BYOD model allows patients to use their own smartphone or other device for data capture during a site visit or remotely. Participants using devices they are already familiar with may lead to better compliance and ultimately, a better clinical trial experience. However, since some participants may be hesitant to download an app on their own device, or may not own a device that meets the requirements, it’s important to anticipate a percentage of provisioned devices, even in trials adopting a BYOD strategy.
The latest in eCOA
eCOA, AI, and Agentic AI: A practical overview and guide
Combining artificial intelligence (AI) and agentic AI with electronic Clinical Outcome Assessment (eCOA) systems fundamentally enhances how clinical trial data is collected, interpreted, and acted upon. At its core, eCOA captures structured data directly from patients, clinicians, or observers, such as symptom severity, quality of life, or functional outcomes. Modern platforms expand this further by supporting a full range of assessment types, including electronic patient-reported outcomes (ePRO), clinician-reported outcomes (eClinRO), observer-reported outcomes (eObsRO), and performance outcomes (ePerfO).
Common missteps when deploying eCOAs in clinical trials
Sometimes when teams deploy eCOA (electronic Clinical Outcome Assessment) in clinical trials, challenges can arise with operational planning, protocol design decisions, or workflow alignment. Below are some of the most common missteps observed across sponsors, CROs, and investigative sites.
1. Treating eCOA as a late-stage add-on
Many teams wait until protocol finalization or even after startup to plan eCOA implementation.
Why this causes problems
- Instrument licensing or translations may not be ready
- Build timelines get compressed
- Protocol schedules may not align with electronic workflows
Best practice
Plan eCOA during protocol design, especially when selecting instruments and defining visit schedules.
Real-world oncology: The eCOA for restored control and quality science
Medable showcases the end-to-end eCOA workflow from both the patient and site perspective during an active oncology study, highlighting real-time symptom reporting, episodic event capture, and a preview of the PI Summary Agent.